Infinity stops cancer trial as drug fails to show

(Reuters) - Infinity Pharmaceuticals said it stopped a mid-stage trial of its experimental pancreatic cancer drug following an interim analysis that showed it would not meet its main goal. Data from the preliminary analysis showed that patients re...